Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

300 Antibody Diagnostic Test Kit (Antibody 300)

This study is enrolling participants by invitation only.
Sponsor:
Collaborator:
Plasma Services Group
Information provided by (Responsible Party):
The Plasma Source
ClinicalTrials.gov Identifier:
NCT01646411
First received: July 12, 2012
Last updated: July 19, 2012
Last verified: July 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is enrolling participants by invitation only.
  Estimated Study Completion Date: July 2013
  Estimated Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)